The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Tropical and Vector-borne Infectious Diseases Market Research Report 2024
Synopsis
Tropical and vector-borne infectious diseases are the most complex to prevent and control among all infectious diseases. Tropical diseases usually occur in hot, humid environments and spread quickly. Many tropical infectious diseases are also insect-borne infectious diseases, which are transmitted from person to person through insect vectors, such as mosquitoes, ticks, fleas, lice and mites.
The global Tropical and Vector-borne Infectious Diseases market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Tropical and Vector-borne Infectious Diseases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tropical and Vector-borne Infectious Diseases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Tropical and Vector-borne Infectious Diseases include Bio-Mapper, Meridian, Bharat Biotech, Inovio Pharmaceuticals and GeneOne Life Sciences, Intrexon, Cerus, Sanofi, Lumos Pharma, Coyote Bio, GlaxoSmithKline, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tropical and Vector-borne Infectious Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tropical and Vector-borne Infectious Diseases.
The Tropical and Vector-borne Infectious Diseases market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Tropical and Vector-borne Infectious Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tropical and Vector-borne Infectious Diseases manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bio-Mapper
Meridian
Bharat Biotech
Inovio Pharmaceuticals and GeneOne Life Sciences
Intrexon
Cerus
Sanofi
Lumos Pharma
Coyote Bio
GlaxoSmithKline
Primerdesign
Bio-Manguinhos
Chumakov
Institut Pasteur de Dakar
Roche Diagnostics
Segment by Type
Drugs
Diagnostic Reagent
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tropical and Vector-borne Infectious Diseases manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tropical and Vector-borne Infectious Diseases in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Tropical and vector-borne infectious diseases are the most complex to prevent and control among all infectious diseases. Tropical diseases usually occur in hot, humid environments and spread quickly. Many tropical infectious diseases are also insect-borne infectious diseases, which are transmitted from person to person through insect vectors, such as mosquitoes, ticks, fleas, lice and mites.
The global Tropical and Vector-borne Infectious Diseases market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Tropical and Vector-borne Infectious Diseases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tropical and Vector-borne Infectious Diseases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Tropical and Vector-borne Infectious Diseases include Bio-Mapper, Meridian, Bharat Biotech, Inovio Pharmaceuticals and GeneOne Life Sciences, Intrexon, Cerus, Sanofi, Lumos Pharma, Coyote Bio, GlaxoSmithKline, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tropical and Vector-borne Infectious Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tropical and Vector-borne Infectious Diseases.
The Tropical and Vector-borne Infectious Diseases market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Tropical and Vector-borne Infectious Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tropical and Vector-borne Infectious Diseases manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bio-Mapper
Meridian
Bharat Biotech
Inovio Pharmaceuticals and GeneOne Life Sciences
Intrexon
Cerus
Sanofi
Lumos Pharma
Coyote Bio
GlaxoSmithKline
Primerdesign
Bio-Manguinhos
Chumakov
Institut Pasteur de Dakar
Roche Diagnostics
Segment by Type
Drugs
Diagnostic Reagent
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tropical and Vector-borne Infectious Diseases manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tropical and Vector-borne Infectious Diseases in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Tropical and Vector-borne Infectious Diseases Market Overview
1.1 Product Definition
1.2 Tropical and Vector-borne Infectious Diseases by Type
1.2.1 Global Tropical and Vector-borne Infectious Diseases Market Value Comparison by Type (2024-2030)
1.2.2 Drugs
1.2.3 Diagnostic Reagent
1.3 Tropical and Vector-borne Infectious Diseases by Application
1.3.1 Global Tropical and Vector-borne Infectious Diseases Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Tropical and Vector-borne Infectious Diseases Market Size Estimates and Forecasts
1.4.1 Global Tropical and Vector-borne Infectious Diseases Revenue 2019-2030
1.4.2 Global Tropical and Vector-borne Infectious Diseases Sales 2019-2030
1.4.3 Global Tropical and Vector-borne Infectious Diseases Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Tropical and Vector-borne Infectious Diseases Market Competition by Manufacturers
2.1 Global Tropical and Vector-borne Infectious Diseases Sales Market Share by Manufacturers (2019-2024)
2.2 Global Tropical and Vector-borne Infectious Diseases Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Tropical and Vector-borne Infectious Diseases Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Tropical and Vector-borne Infectious Diseases, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tropical and Vector-borne Infectious Diseases, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tropical and Vector-borne Infectious Diseases, Product Type & Application
2.7 Global Key Manufacturers of Tropical and Vector-borne Infectious Diseases, Date of Enter into This Industry
2.8 Global Tropical and Vector-borne Infectious Diseases Market Competitive Situation and Trends
2.8.1 Global Tropical and Vector-borne Infectious Diseases Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tropical and Vector-borne Infectious Diseases Players Market Share by Revenue
2.8.3 Global Tropical and Vector-borne Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tropical and Vector-borne Infectious Diseases Market Scenario by Region
3.1 Global Tropical and Vector-borne Infectious Diseases Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Tropical and Vector-borne Infectious Diseases Sales by Region: 2019-2030
3.2.1 Global Tropical and Vector-borne Infectious Diseases Sales by Region: 2019-2024
3.2.2 Global Tropical and Vector-borne Infectious Diseases Sales by Region: 2025-2030
3.3 Global Tropical and Vector-borne Infectious Diseases Revenue by Region: 2019-2030
3.3.1 Global Tropical and Vector-borne Infectious Diseases Revenue by Region: 2019-2024
3.3.2 Global Tropical and Vector-borne Infectious Diseases Revenue by Region: 2025-2030
3.4 North America Tropical and Vector-borne Infectious Diseases Market Facts & Figures by Country
3.4.1 North America Tropical and Vector-borne Infectious Diseases Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Tropical and Vector-borne Infectious Diseases Sales by Country (2019-2030)
3.4.3 North America Tropical and Vector-borne Infectious Diseases Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tropical and Vector-borne Infectious Diseases Market Facts & Figures by Country
3.5.1 Europe Tropical and Vector-borne Infectious Diseases Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Tropical and Vector-borne Infectious Diseases Sales by Country (2019-2030)
3.5.3 Europe Tropical and Vector-borne Infectious Diseases Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tropical and Vector-borne Infectious Diseases Market Facts & Figures by Region
3.6.1 Asia Pacific Tropical and Vector-borne Infectious Diseases Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Tropical and Vector-borne Infectious Diseases Sales by Region (2019-2030)
3.6.3 Asia Pacific Tropical and Vector-borne Infectious Diseases Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Tropical and Vector-borne Infectious Diseases Market Facts & Figures by Country
3.7.1 Latin America Tropical and Vector-borne Infectious Diseases Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Tropical and Vector-borne Infectious Diseases Sales by Country (2019-2030)
3.7.3 Latin America Tropical and Vector-borne Infectious Diseases Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Tropical and Vector-borne Infectious Diseases Market Facts & Figures by Country
3.8.1 Middle East and Africa Tropical and Vector-borne Infectious Diseases Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Tropical and Vector-borne Infectious Diseases Sales by Country (2019-2030)
3.8.3 Middle East and Africa Tropical and Vector-borne Infectious Diseases Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tropical and Vector-borne Infectious Diseases Sales by Type (2019-2030)
4.1.1 Global Tropical and Vector-borne Infectious Diseases Sales by Type (2019-2024)
4.1.2 Global Tropical and Vector-borne Infectious Diseases Sales by Type (2025-2030)
4.1.3 Global Tropical and Vector-borne Infectious Diseases Sales Market Share by Type (2019-2030)
4.2 Global Tropical and Vector-borne Infectious Diseases Revenue by Type (2019-2030)
4.2.1 Global Tropical and Vector-borne Infectious Diseases Revenue by Type (2019-2024)
4.2.2 Global Tropical and Vector-borne Infectious Diseases Revenue by Type (2025-2030)
4.2.3 Global Tropical and Vector-borne Infectious Diseases Revenue Market Share by Type (2019-2030)
4.3 Global Tropical and Vector-borne Infectious Diseases Price by Type (2019-2030)
5 Segment by Application
5.1 Global Tropical and Vector-borne Infectious Diseases Sales by Application (2019-2030)
5.1.1 Global Tropical and Vector-borne Infectious Diseases Sales by Application (2019-2024)
5.1.2 Global Tropical and Vector-borne Infectious Diseases Sales by Application (2025-2030)
5.1.3 Global Tropical and Vector-borne Infectious Diseases Sales Market Share by Application (2019-2030)
5.2 Global Tropical and Vector-borne Infectious Diseases Revenue by Application (2019-2030)
5.2.1 Global Tropical and Vector-borne Infectious Diseases Revenue by Application (2019-2024)
5.2.2 Global Tropical and Vector-borne Infectious Diseases Revenue by Application (2025-2030)
5.2.3 Global Tropical and Vector-borne Infectious Diseases Revenue Market Share by Application (2019-2030)
5.3 Global Tropical and Vector-borne Infectious Diseases Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bio-Mapper
6.1.1 Bio-Mapper Company Information
6.1.2 Bio-Mapper Description and Business Overview
6.1.3 Bio-Mapper Tropical and Vector-borne Infectious Diseases Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bio-Mapper Tropical and Vector-borne Infectious Diseases Product Portfolio
6.1.5 Bio-Mapper Recent Developments/Updates
6.2 Meridian
6.2.1 Meridian Company Information
6.2.2 Meridian Description and Business Overview
6.2.3 Meridian Tropical and Vector-borne Infectious Diseases Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Meridian Tropical and Vector-borne Infectious Diseases Product Portfolio
6.2.5 Meridian Recent Developments/Updates
6.3 Bharat Biotech
6.3.1 Bharat Biotech Company Information
6.3.2 Bharat Biotech Description and Business Overview
6.3.3 Bharat Biotech Tropical and Vector-borne Infectious Diseases Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bharat Biotech Tropical and Vector-borne Infectious Diseases Product Portfolio
6.3.5 Bharat Biotech Recent Developments/Updates
6.4 Inovio Pharmaceuticals and GeneOne Life Sciences
6.4.1 Inovio Pharmaceuticals and GeneOne Life Sciences Company Information
6.4.2 Inovio Pharmaceuticals and GeneOne Life Sciences Description and Business Overview
6.4.3 Inovio Pharmaceuticals and GeneOne Life Sciences Tropical and Vector-borne Infectious Diseases Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Inovio Pharmaceuticals and GeneOne Life Sciences Tropical and Vector-borne Infectious Diseases Product Portfolio
6.4.5 Inovio Pharmaceuticals and GeneOne Life Sciences Recent Developments/Updates
6.5 Intrexon
6.5.1 Intrexon Company Information
6.5.2 Intrexon Description and Business Overview
6.5.3 Intrexon Tropical and Vector-borne Infectious Diseases Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Intrexon Tropical and Vector-borne Infectious Diseases Product Portfolio
6.5.5 Intrexon Recent Developments/Updates
6.6 Cerus
6.6.1 Cerus Company Information
6.6.2 Cerus Description and Business Overview
6.6.3 Cerus Tropical and Vector-borne Infectious Diseases Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cerus Tropical and Vector-borne Infectious Diseases Product Portfolio
6.6.5 Cerus Recent Developments/Updates
6.7 Sanofi
6.7.1 Sanofi Company Information
6.7.2 Sanofi Description and Business Overview
6.7.3 Sanofi Tropical and Vector-borne Infectious Diseases Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Sanofi Tropical and Vector-borne Infectious Diseases Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Lumos Pharma
6.8.1 Lumos Pharma Company Information
6.8.2 Lumos Pharma Description and Business Overview
6.8.3 Lumos Pharma Tropical and Vector-borne Infectious Diseases Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Lumos Pharma Tropical and Vector-borne Infectious Diseases Product Portfolio
6.8.5 Lumos Pharma Recent Developments/Updates
6.9 Coyote Bio
6.9.1 Coyote Bio Company Information
6.9.2 Coyote Bio Description and Business Overview
6.9.3 Coyote Bio Tropical and Vector-borne Infectious Diseases Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Coyote Bio Tropical and Vector-borne Infectious Diseases Product Portfolio
6.9.5 Coyote Bio Recent Developments/Updates
6.10 GlaxoSmithKline
6.10.1 GlaxoSmithKline Company Information
6.10.2 GlaxoSmithKline Description and Business Overview
6.10.3 GlaxoSmithKline Tropical and Vector-borne Infectious Diseases Sales, Revenue and Gross Margin (2019-2024)
6.10.4 GlaxoSmithKline Tropical and Vector-borne Infectious Diseases Product Portfolio
6.10.5 GlaxoSmithKline Recent Developments/Updates
6.11 Primerdesign
6.11.1 Primerdesign Company Information
6.11.2 Primerdesign Description and Business Overview
6.11.3 Primerdesign Tropical and Vector-borne Infectious Diseases Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Primerdesign Tropical and Vector-borne Infectious Diseases Product Portfolio
6.11.5 Primerdesign Recent Developments/Updates
6.12 Bio-Manguinhos
6.12.1 Bio-Manguinhos Company Information
6.12.2 Bio-Manguinhos Description and Business Overview
6.12.3 Bio-Manguinhos Tropical and Vector-borne Infectious Diseases Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Bio-Manguinhos Tropical and Vector-borne Infectious Diseases Product Portfolio
6.12.5 Bio-Manguinhos Recent Developments/Updates
6.13 Chumakov
6.13.1 Chumakov Company Information
6.13.2 Chumakov Description and Business Overview
6.13.3 Chumakov Tropical and Vector-borne Infectious Diseases Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Chumakov Tropical and Vector-borne Infectious Diseases Product Portfolio
6.13.5 Chumakov Recent Developments/Updates
6.14 Institut Pasteur de Dakar
6.14.1 Institut Pasteur de Dakar Company Information
6.14.2 Institut Pasteur de Dakar Description and Business Overview
6.14.3 Institut Pasteur de Dakar Tropical and Vector-borne Infectious Diseases Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Institut Pasteur de Dakar Tropical and Vector-borne Infectious Diseases Product Portfolio
6.14.5 Institut Pasteur de Dakar Recent Developments/Updates
6.15 Roche Diagnostics
6.15.1 Roche Diagnostics Company Information
6.15.2 Roche Diagnostics Description and Business Overview
6.15.3 Roche Diagnostics Tropical and Vector-borne Infectious Diseases Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Roche Diagnostics Tropical and Vector-borne Infectious Diseases Product Portfolio
6.15.5 Roche Diagnostics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tropical and Vector-borne Infectious Diseases Industry Chain Analysis
7.2 Tropical and Vector-borne Infectious Diseases Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tropical and Vector-borne Infectious Diseases Production Mode & Process
7.4 Tropical and Vector-borne Infectious Diseases Sales and Marketing
7.4.1 Tropical and Vector-borne Infectious Diseases Sales Channels
7.4.2 Tropical and Vector-borne Infectious Diseases Distributors
7.5 Tropical and Vector-borne Infectious Diseases Customers
8 Tropical and Vector-borne Infectious Diseases Market Dynamics
8.1 Tropical and Vector-borne Infectious Diseases Industry Trends
8.2 Tropical and Vector-borne Infectious Diseases Market Drivers
8.3 Tropical and Vector-borne Infectious Diseases Market Challenges
8.4 Tropical and Vector-borne Infectious Diseases Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Tropical and Vector-borne Infectious Diseases Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Tropical and Vector-borne Infectious Diseases Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Tropical and Vector-borne Infectious Diseases Market Competitive Situation by Manufacturers in 2023
Table 4. Global Tropical and Vector-borne Infectious Diseases Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Tropical and Vector-borne Infectious Diseases Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Tropical and Vector-borne Infectious Diseases Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Tropical and Vector-borne Infectious Diseases Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Tropical and Vector-borne Infectious Diseases Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Tropical and Vector-borne Infectious Diseases, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Tropical and Vector-borne Infectious Diseases, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tropical and Vector-borne Infectious Diseases, Product Type & Application
Table 12. Global Key Manufacturers of Tropical and Vector-borne Infectious Diseases, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tropical and Vector-borne Infectious Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tropical and Vector-borne Infectious Diseases as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tropical and Vector-borne Infectious Diseases Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Tropical and Vector-borne Infectious Diseases Sales by Region (2019-2024) & (K Units)
Table 18. Global Tropical and Vector-borne Infectious Diseases Sales Market Share by Region (2019-2024)
Table 19. Global Tropical and Vector-borne Infectious Diseases Sales by Region (2025-2030) & (K Units)
Table 20. Global Tropical and Vector-borne Infectious Diseases Sales Market Share by Region (2025-2030)
Table 21. Global Tropical and Vector-borne Infectious Diseases Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Tropical and Vector-borne Infectious Diseases Revenue Market Share by Region (2019-2024)
Table 23. Global Tropical and Vector-borne Infectious Diseases Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Tropical and Vector-borne Infectious Diseases Revenue Market Share by Region (2025-2030)
Table 25. North America Tropical and Vector-borne Infectious Diseases Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Tropical and Vector-borne Infectious Diseases Sales by Country (2019-2024) & (K Units)
Table 27. North America Tropical and Vector-borne Infectious Diseases Sales by Country (2025-2030) & (K Units)
Table 28. North America Tropical and Vector-borne Infectious Diseases Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Tropical and Vector-borne Infectious Diseases Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Tropical and Vector-borne Infectious Diseases Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Tropical and Vector-borne Infectious Diseases Sales by Country (2019-2024) & (K Units)
Table 32. Europe Tropical and Vector-borne Infectious Diseases Sales by Country (2025-2030) & (K Units)
Table 33. Europe Tropical and Vector-borne Infectious Diseases Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Tropical and Vector-borne Infectious Diseases Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Tropical and Vector-borne Infectious Diseases Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Tropical and Vector-borne Infectious Diseases Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Tropical and Vector-borne Infectious Diseases Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Tropical and Vector-borne Infectious Diseases Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Tropical and Vector-borne Infectious Diseases Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Tropical and Vector-borne Infectious Diseases Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Tropical and Vector-borne Infectious Diseases Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Tropical and Vector-borne Infectious Diseases Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Tropical and Vector-borne Infectious Diseases Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Tropical and Vector-borne Infectious Diseases Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Tropical and Vector-borne Infectious Diseases Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Tropical and Vector-borne Infectious Diseases Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Tropical and Vector-borne Infectious Diseases Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Tropical and Vector-borne Infectious Diseases Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Tropical and Vector-borne Infectious Diseases Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Tropical and Vector-borne Infectious Diseases Sales (K Units) by Type (2019-2024)
Table 51. Global Tropical and Vector-borne Infectious Diseases Sales (K Units) by Type (2025-2030)
Table 52. Global Tropical and Vector-borne Infectious Diseases Sales Market Share by Type (2019-2024)
Table 53. Global Tropical and Vector-borne Infectious Diseases Sales Market Share by Type (2025-2030)
Table 54. Global Tropical and Vector-borne Infectious Diseases Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Tropical and Vector-borne Infectious Diseases Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Tropical and Vector-borne Infectious Diseases Revenue Market Share by Type (2019-2024)
Table 57. Global Tropical and Vector-borne Infectious Diseases Revenue Market Share by Type (2025-2030)
Table 58. Global Tropical and Vector-borne Infectious Diseases Price (US$/Unit) by Type (2019-2024)
Table 59. Global Tropical and Vector-borne Infectious Diseases Price (US$/Unit) by Type (2025-2030)
Table 60. Global Tropical and Vector-borne Infectious Diseases Sales (K Units) by Application (2019-2024)
Table 61. Global Tropical and Vector-borne Infectious Diseases Sales (K Units) by Application (2025-2030)
Table 62. Global Tropical and Vector-borne Infectious Diseases Sales Market Share by Application (2019-2024)
Table 63. Global Tropical and Vector-borne Infectious Diseases Sales Market Share by Application (2025-2030)
Table 64. Global Tropical and Vector-borne Infectious Diseases Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Tropical and Vector-borne Infectious Diseases Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Tropical and Vector-borne Infectious Diseases Revenue Market Share by Application (2019-2024)
Table 67. Global Tropical and Vector-borne Infectious Diseases Revenue Market Share by Application (2025-2030)
Table 68. Global Tropical and Vector-borne Infectious Diseases Price (US$/Unit) by Application (2019-2024)
Table 69. Global Tropical and Vector-borne Infectious Diseases Price (US$/Unit) by Application (2025-2030)
Table 70. Bio-Mapper Company Information
Table 71. Bio-Mapper Description and Business Overview
Table 72. Bio-Mapper Tropical and Vector-borne Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Bio-Mapper Tropical and Vector-borne Infectious Diseases Product
Table 74. Bio-Mapper Recent Developments/Updates
Table 75. Meridian Company Information
Table 76. Meridian Description and Business Overview
Table 77. Meridian Tropical and Vector-borne Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Meridian Tropical and Vector-borne Infectious Diseases Product
Table 79. Meridian Recent Developments/Updates
Table 80. Bharat Biotech Company Information
Table 81. Bharat Biotech Description and Business Overview
Table 82. Bharat Biotech Tropical and Vector-borne Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Bharat Biotech Tropical and Vector-borne Infectious Diseases Product
Table 84. Bharat Biotech Recent Developments/Updates
Table 85. Inovio Pharmaceuticals and GeneOne Life Sciences Company Information
Table 86. Inovio Pharmaceuticals and GeneOne Life Sciences Description and Business Overview
Table 87. Inovio Pharmaceuticals and GeneOne Life Sciences Tropical and Vector-borne Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Inovio Pharmaceuticals and GeneOne Life Sciences Tropical and Vector-borne Infectious Diseases Product
Table 89. Inovio Pharmaceuticals and GeneOne Life Sciences Recent Developments/Updates
Table 90. Intrexon Company Information
Table 91. Intrexon Description and Business Overview
Table 92. Intrexon Tropical and Vector-borne Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Intrexon Tropical and Vector-borne Infectious Diseases Product
Table 94. Intrexon Recent Developments/Updates
Table 95. Cerus Company Information
Table 96. Cerus Description and Business Overview
Table 97. Cerus Tropical and Vector-borne Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Cerus Tropical and Vector-borne Infectious Diseases Product
Table 99. Cerus Recent Developments/Updates
Table 100. Sanofi Company Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Tropical and Vector-borne Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Sanofi Tropical and Vector-borne Infectious Diseases Product
Table 104. Sanofi Recent Developments/Updates
Table 105. Lumos Pharma Company Information
Table 106. Lumos Pharma Description and Business Overview
Table 107. Lumos Pharma Tropical and Vector-borne Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Lumos Pharma Tropical and Vector-borne Infectious Diseases Product
Table 109. Lumos Pharma Recent Developments/Updates
Table 110. Coyote Bio Company Information
Table 111. Coyote Bio Description and Business Overview
Table 112. Coyote Bio Tropical and Vector-borne Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Coyote Bio Tropical and Vector-borne Infectious Diseases Product
Table 114. Coyote Bio Recent Developments/Updates
Table 115. GlaxoSmithKline Company Information
Table 116. GlaxoSmithKline Description and Business Overview
Table 117. GlaxoSmithKline Tropical and Vector-borne Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. GlaxoSmithKline Tropical and Vector-borne Infectious Diseases Product
Table 119. GlaxoSmithKline Recent Developments/Updates
Table 120. Primerdesign Company Information
Table 121. Primerdesign Description and Business Overview
Table 122. Primerdesign Tropical and Vector-borne Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Primerdesign Tropical and Vector-borne Infectious Diseases Product
Table 124. Primerdesign Recent Developments/Updates
Table 125. Bio-Manguinhos Company Information
Table 126. Bio-Manguinhos Description and Business Overview
Table 127. Bio-Manguinhos Tropical and Vector-borne Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Bio-Manguinhos Tropical and Vector-borne Infectious Diseases Product
Table 129. Bio-Manguinhos Recent Developments/Updates
Table 130. Chumakov Company Information
Table 131. Chumakov Description and Business Overview
Table 132. Chumakov Tropical and Vector-borne Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Chumakov Tropical and Vector-borne Infectious Diseases Product
Table 134. Chumakov Recent Developments/Updates
Table 135. Institut Pasteur de Dakar Company Information
Table 136. Institut Pasteur de Dakar Description and Business Overview
Table 137. Institut Pasteur de Dakar Tropical and Vector-borne Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Institut Pasteur de Dakar Tropical and Vector-borne Infectious Diseases Product
Table 139. Institut Pasteur de Dakar Recent Developments/Updates
Table 140. Roche Diagnostics Company Information
Table 141. Roche Diagnostics Description and Business Overview
Table 142. Roche Diagnostics Tropical and Vector-borne Infectious Diseases Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Roche Diagnostics Tropical and Vector-borne Infectious Diseases Product
Table 144. Roche Diagnostics Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Tropical and Vector-borne Infectious Diseases Distributors List
Table 148. Tropical and Vector-borne Infectious Diseases Customers List
Table 149. Tropical and Vector-borne Infectious Diseases Market Trends
Table 150. Tropical and Vector-borne Infectious Diseases Market Drivers
Table 151. Tropical and Vector-borne Infectious Diseases Market Challenges
Table 152. Tropical and Vector-borne Infectious Diseases Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Tropical and Vector-borne Infectious Diseases
Figure 2. Global Tropical and Vector-borne Infectious Diseases Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Tropical and Vector-borne Infectious Diseases Market Share by Type: 2023 & 2030
Figure 4. Drugs Product Picture
Figure 5. Diagnostic Reagent Product Picture
Figure 6. Global Tropical and Vector-borne Infectious Diseases Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Tropical and Vector-borne Infectious Diseases Market Share by Application: 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Tropical and Vector-borne Infectious Diseases Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Tropical and Vector-borne Infectious Diseases Market Size (2019-2030) & (US$ Million)
Figure 13. Global Tropical and Vector-borne Infectious Diseases Sales (2019-2030) & (K Units)
Figure 14. Global Tropical and Vector-borne Infectious Diseases Average Price (US$/Unit) & (2019-2030)
Figure 15. Tropical and Vector-borne Infectious Diseases Report Years Considered
Figure 16. Tropical and Vector-borne Infectious Diseases Sales Share by Manufacturers in 2023
Figure 17. Global Tropical and Vector-borne Infectious Diseases Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest Tropical and Vector-borne Infectious Diseases Players: Market Share by Revenue in Tropical and Vector-borne Infectious Diseases in 2023
Figure 19. Tropical and Vector-borne Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global Tropical and Vector-borne Infectious Diseases Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Tropical and Vector-borne Infectious Diseases Sales Market Share by Country (2019-2030)
Figure 22. North America Tropical and Vector-borne Infectious Diseases Revenue Market Share by Country (2019-2030)
Figure 23. United States Tropical and Vector-borne Infectious Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Tropical and Vector-borne Infectious Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Tropical and Vector-borne Infectious Diseases Sales Market Share by Country (2019-2030)
Figure 26. Europe Tropical and Vector-borne Infectious Diseases Revenue Market Share by Country (2019-2030)
Figure 27. Germany Tropical and Vector-borne Infectious Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Tropical and Vector-borne Infectious Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Tropical and Vector-borne Infectious Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Tropical and Vector-borne Infectious Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Tropical and Vector-borne Infectious Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Tropical and Vector-borne Infectious Diseases Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Tropical and Vector-borne Infectious Diseases Revenue Market Share by Region (2019-2030)
Figure 34. China Tropical and Vector-borne Infectious Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Tropical and Vector-borne Infectious Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Tropical and Vector-borne Infectious Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Tropical and Vector-borne Infectious Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Tropical and Vector-borne Infectious Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Tropical and Vector-borne Infectious Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Tropical and Vector-borne Infectious Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Tropical and Vector-borne Infectious Diseases Sales Market Share by Country (2019-2030)
Figure 42. Mexico Tropical and Vector-borne Infectious Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Tropical and Vector-borne Infectious Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Tropical and Vector-borne Infectious Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Tropical and Vector-borne Infectious Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa Tropical and Vector-borne Infectious Diseases Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa Tropical and Vector-borne Infectious Diseases Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Tropical and Vector-borne Infectious Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Tropical and Vector-borne Infectious Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Tropical and Vector-borne Infectious Diseases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Tropical and Vector-borne Infectious Diseases by Type (2019-2030)
Figure 52. Global Revenue Market Share of Tropical and Vector-borne Infectious Diseases by Type (2019-2030)
Figure 53. Global Tropical and Vector-borne Infectious Diseases Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Tropical and Vector-borne Infectious Diseases by Application (2019-2030)
Figure 55. Global Revenue Market Share of Tropical and Vector-borne Infectious Diseases by Application (2019-2030)
Figure 56. Global Tropical and Vector-borne Infectious Diseases Price (US$/Unit) by Application (2019-2030)
Figure 57. Tropical and Vector-borne Infectious Diseases Value Chain
Figure 58. Tropical and Vector-borne Infectious Diseases Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
